JNJ Q2 2024 Sales Surge To $22.4 Billion, Beating Expectations

Johnson & Johnson reported a 4.3% increase in sales to $22.4 billion in Q2 2024, with operational growth at 6.6% and adjusted EPS rising by 10.2% to $2.82.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.